Transfer of Research Functions and Closure of Research Facilities Through the Absorption Merger of H3 Biomedicine

A specific research organization restructuring involving the absorption merger of H3 Biomedicine into Eisai Inc., the transfer of its research functions, drug discovery platform and R&D products within the Group, and the closure of its offices and research laboratories.